J. Maslin (Biologiste, spécialiste des Hôpitaux des Armées) , M. Develoux (Praticien hospitalier)
{"title":"Actualités thérapeutiques des mycoses rares en dehors des mycoses opportunistes","authors":"J. Maslin (Biologiste, spécialiste des Hôpitaux des Armées) , M. Develoux (Praticien hospitalier)","doi":"10.1016/j.emcmi.2004.07.001","DOIUrl":null,"url":null,"abstract":"<div><p>The therapeutic management of unusual mycosis which occur essentially in tropical areas has considerably improved the prognosis of this disease. Some new antifungal agents are under evaluation. There is no treatment of choice for rare mycosis, but recent trials on series of therapeutic options have generated recommendations. The selection of a treatment should consider several conditions, such as their cost, their secondary effects, but also the diagnosis possibility, and the health status of the patient.</p></div>","PeriodicalId":100430,"journal":{"name":"EMC - Maladies Infectieuses","volume":"1 4","pages":"Pages 302-312"},"PeriodicalIF":0.0000,"publicationDate":"2004-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcmi.2004.07.001","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Maladies Infectieuses","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1638623X04000162","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
The therapeutic management of unusual mycosis which occur essentially in tropical areas has considerably improved the prognosis of this disease. Some new antifungal agents are under evaluation. There is no treatment of choice for rare mycosis, but recent trials on series of therapeutic options have generated recommendations. The selection of a treatment should consider several conditions, such as their cost, their secondary effects, but also the diagnosis possibility, and the health status of the patient.